IF by specialty › Urology & Nephrology
European Urology Oncology — Impact Factor
The 2025 Impact Factor of European Urology Oncology is 8.5 (quartile not confirmed; subscription or hybrid).
- Impact Factor
- 8.5 JCR 2025
- JCR category
- Urology & Nephrology
- Quartile
- quartile not confirmed
- Publisher
- Elsevier (European Association of Urology)
- Open access
- subscription or hybrid
- IF source
- sciencedirect.com
Position within the field
Ranked 7 of the 41 journals in Urology & Nephrology on this site (top 25%).
Urology & Nephrology journals with a similar Impact Factor
- Journal of the American Society of Nephrology IF 10.1
- American Journal of Kidney Diseases IF 9.4
- Nephrology Dialysis Transplantation IF 8.3
- Clinical Journal of the American Society of Nephrology IF 8.2
- The Journal of Urology IF 6.8
- European Urology Focus IF 6.3
About this value
The Journal Impact Factor of European Urology Oncology (JCR 2025, released June 2026) is 8.5. Values are compiled by cross-checking figures published by publishers and societies against public aggregators; this is not a reproduction of Clarivate Journal Citation Reports™. Confirm the current value on the publisher's page or in JCR before deciding where to submit. The quartile (Q1–Q4) is the journal's relative position within its JCR category; Q1 means the top 25%.
Last updated September 2026. Report errors via the contact form. Other journals in the same category: Urology & Nephrology.